Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 17;50(2):420-429.
doi: 10.1093/ije/dyab012.

The role of C-reactive protein as a prognostic marker in COVID-19

Dominic Stringer  1 , Philip Braude  2 , Phyo K Myint  3 , Louis Evans  4 , Jemima T Collins  5 , Alessia Verduri  6 , Terry J Quinn  7 , Arturo Vilches-Moraga  8 , Michael J Stechman  9 , Lyndsay Pearce  10 , Susan Moug  11 , Kathryn McCarthy  12 , Jonathan Hewitt  13 , Ben Carter  1 ; COPE Study Collaborators
Collaborators, Affiliations

The role of C-reactive protein as a prognostic marker in COVID-19

Dominic Stringer et al. Int J Epidemiol. .

Abstract

Background: C-reactive protein (CRP) is a non-specific acute phase reactant elevated in infection or inflammation. Higher levels indicate more severe infection and have been used as an indicator of COVID-19 disease severity. However, the evidence for CRP as a prognostic marker is yet to be determined. The aim of this study is to examine the CRP response in patients hospitalized with COVID-19 and to determine the utility of CRP on admission for predicting inpatient mortality.

Methods: Data were collected between 27 February and 10 June 2020, incorporating two cohorts: the COPE (COVID-19 in Older People) study of 1564 adult patients with a diagnosis of COVID-19 admitted to 11 hospital sites (test cohort) and a later validation cohort of 271 patients. Admission CRP was investigated, and finite mixture models were fit to assess the likely underlying distribution. Further, different prognostic thresholds of CRP were analysed in a time-to-mortality Cox regression to determine a cut-off. Bootstrapping was used to compare model performance [Harrell's C statistic and Akaike information criterion (AIC)].

Results: The test and validation cohort distribution of CRP was not affected by age, and mixture models indicated a bimodal distribution. A threshold cut-off of CRP ≥40 mg/L performed well to predict mortality (and performed similarly to treating CRP as a linear variable).

Conclusions: The distributional characteristics of CRP indicated an optimal cut-off of ≥40 mg/L was associated with mortality. This threshold may assist clinicians in using CRP as an early trigger for enhanced observation, treatment decisions and advanced care planning.

Keywords: COVID-19; CRP; bimodal; mixture model; mortality; prognostic marker; trimodal.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of C-reactive protein (CRP) in the original cohort (left panel) and the validation cohort (right panel), overlaid predicted distributions from a two-class (upper row), compared with three-class (lower row) finite mixture models
See this image and copyright information in PMC

References

    1. Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13. - PMC - PubMed
    1. Liu F, Li L, Xu M. et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020;127:104370. - PMC - PubMed
    1. Pepys MB, Hirschfield GM.. C-reactive protein: a critical update. J Clin Invest 2003;111:1805–12. - PMC - PubMed
    1. Haran JP, Beaudoin FL, Suner S, Lu S.. C-reactive protein as predictor of bacterial infection among patients with an influenza-like illness. Am J Emerg Med 2013;31:137–44. - PubMed
    1. Li Q, Ding X, Xia G. et al. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study. EclinMed 2020;23:100375. - PMC - PubMed

Publication types